Stay updated with breaking news from Phil robilotto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ GEn1E Lifesciences, a next-generation multitarget techbio company developing novel and targeted immunomodulators, has secured an exclusive,. ....
GEn1E Lifesciences Adds NextGen Selective Immunomodulator Target to Portfolio, Broadens Pipeline - read this article along with other careers information, tips and advice on BioSpace ....
/PRNewswire/ CoapTech, Inc, a medical device company focused on delivering transformative solutions for minimally-invasive surgery, announced today. ....
GlycoMantra, a University of Maryland, Baltimore (UMB) startup company developing therapeutics for unmet medical needs in prostate cancer, NASH liver fibrosis, and type 2 diabetes, has been granted worldwide, exclusive rights to a UMB technology to advance the company's pipeline of therapeutics for treating drug-resistant metastatic colorectal cancer (mCRC). ....